<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
p.gmail-font-copy, li.gmail-font-copy, div.gmail-font-copy
{mso-style-name:gmail-font-copy;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.gmail-apple-converted-space
{mso-style-name:gmail-apple-converted-space;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal">Kind of get the feeling that surveillance deep in Africa isn’t close to telling the whole story, eh? How many chapters of this story have just been missed completely?<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b>From:</b> Friam <friam-bounces@redfish.com> <b>On Behalf Of
</b>Merle Lefkoff<br>
<b>Sent:</b> Monday, November 29, 2021 10:12 AM<br>
<b>To:</b> The Friday Morning Applied Complexity Coffee Group <friam@redfish.com><br>
<b>Subject:</b> [FRIAM] Omicron--what we know now<o:p></o:p></p>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div>
<p class="gmail-font-copy" style="margin:0in"><span style="font-size:10.0pt;font-family:"Georgia",serif;color:#2A2A2A">Omicron’s genetic profile is unique from other circulating variants, meaning it represents a new lineage of the virus.<span class="gmail-apple-converted-space"> </span></span><span style="font-size:13.5pt;font-family:"Times New Roman",serif;color:black"><o:p></o:p></span></p>
<p class="gmail-font-copy" style="margin:0in"><span style="font-size:10.0pt;font-family:"Georgia",serif;color:#2A2A2A"> </span><span style="font-size:13.5pt;font-family:"Times New Roman",serif;color:black"><o:p></o:p></span></p>
<p class="gmail-font-copy" style="margin:0in"><span style="font-size:10.0pt;font-family:"Georgia",serif;color:#2A2A2A">It is distinct from other variants in another crucial way: There are a greater number of mutations. Tulio de Oliveira, director of the Center
for Epidemic Response and Innovation in South Africa, said there are more than 30 mutations in the spike protein, the part of the virus that binds to human cells, allowing it to gain entry.</span><span style="font-size:13.5pt;font-family:"Times New Roman",serif;color:black"><o:p></o:p></span></p>
<p class="gmail-font-copy" style="margin:0in;font-size:1.25rem;outline:none"><span style="font-size:10.0pt;font-family:"Georgia",serif;color:#2A2A2A"> </span><span style="font-family:"Times New Roman",serif;color:black"><o:p></o:p></span></p>
<p class="gmail-font-copy" style="margin:0in"><span style="font-size:10.0pt;font-family:"Georgia",serif;color:#2A2A2A">Scientists are worried that those mutations could make omicron more transmissible and potentially equipped to defy immune defenses, making
vaccines less effective. The WHO said last week that preliminary evidence suggests an “increased risk of reinfection” compared with other variants.</span><span style="font-size:13.5pt;font-family:"Times New Roman",serif;color:black"><o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p class="MsoNormal">-- <o:p></o:p></p>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal">Merle Lefkoff, Ph.D.<br>
Center for Emergent Diplomacy<br>
<a href="http://emergentdiplomacy.org" target="_blank">emergentdiplomacy.org</a><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">Santa Fe, New Mexico, USA<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>